Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003517035 | SCV004319563 | likely benign | Neuroblastoma, susceptibility to, 3 | 2023-09-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004634296 | SCV005124372 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-06-07 | criteria provided, single submitter | clinical testing | The c.4074-5T>C intronic variant results from a T to C substitution 5 nucleotides upstream from coding exon 28 in the ALK gene. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Based on the available evidence, the clinical significance of this variant remains unclear. |